EI
CLPT icon

EAM Investors’s ClearPoint Neuro CLPT Stock Holding History

EAM Investors’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-211,664
Closed -$4.56M – 293
2025
Q3 		$4.56M Buy
+211,664
New +$2.49M 0.52% 76
2025
Q2 		– Sell
-49,177
Closed -$585K – 252
2025
Q1 		$585K Buy
49,177
+1,143
+2% +$17.8K 0.1% 208
2024
Q4 		$739K Sell
48,034
-30,958
-39% -$401K 0.1% 226
2024
Q3 		$886K Buy
+78,992
New +$756K 0.13% 176
2022
Q4 		– Sell
-113,220
Closed -$1.17M – 270
2022
Q3 		$1.17M Buy
113,220
+25,337
+29% +$334K 0.26% 175
2022
Q2 		$1.15M Buy
+87,883
New +$898K 0.28% 169
2021
Q1 		– Sell
-105,928
Closed -$1.68M – 356
2020
Q4 		$1.68M Buy
+105,928
New +$950K 0.28% 170
2020
Q2 		– Sell
-136,525
Closed -$489K – 265
2020
Q1 		$489K Buy
+136,525
New +$671K 0.15% 198

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
FCM
FirstWave Capital Management Miami, Florida $94.1M AUM
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

EAM Investors's CLPT Position: Q4 2025 in Review

EAM Investors sold out of ClearPoint Neuro (CLPT) in Q4 2025, closing a stake of 211,664 shares — an estimated $4.56M sold.

EAM Investors first reported a position in CLPT in Q1 2020 and held it in 8 quarters. The position peaked at $4.56M in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q4 2025.

  • EAM Investors reported no remaining ClearPoint Neuro position as of Q4 2025 after selling out during the quarter.
  • EAM Investors sold 211,664 ClearPoint Neuro shares in Q4 2025, an estimated $4.56M.
  • EAM Investors first reported a position in ClearPoint Neuro in Q1 2020 and held it in 8 quarters.
  • EAM Investors's ClearPoint Neuro position peaked at $4.56M in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2025.

Based on EAM Investors's 13F filing for Q4 2025, filed 12 Feb 2026.